Clinical Trials for Ella Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Ella Therapeutics

Clinical Trials (3)

NCT06653842
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
PHASE2Recruiting
15 participants
Started: Dec 20, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor10 locations
NCT06239480
SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations
PHASE3Recruiting
40 participants
Started: Jul 31, 2024 · Completed: Jul 31, 2026
1 condition2 sponsors15 locations
NCT05643872
A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita
PHASE3Recruiting
45 participants
Started: Nov 15, 2022 · Completed: Nov 30, 2023
1 condition1 sponsor1 location